secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2023-01-25T23:59:59+00:00
Accession:  0001193125-23-015157
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics regains compliance with Nasdaq MVLS requirement, delisting avoided
--------------------------------------------------------------------------------

- Received Nasdaq letter confirming compliance with $50M MVLS requirement for continued listing on Nasdaq Global Market.
- Hearing before Nasdaq Hearings Panel on Jan 26, 2023 cancelled.
- Company had previously been notified of non-compliance in Dec 2022 and appealed delisting.
- Common stock (GRTX) will continue trading on Nasdaq Global Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312523015157/0001193125-23-015157-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312523015157/d441370d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-015157

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer